LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring
Completed · Not applicable
Conditions studied: Safety
In brief
Errors and preventable adverse events associated with medication prescription and dispensing are common, and the difference between guideline recommendations and the actual frequency of laboratory monitoring is substantial. This study evaluates three interventions to improve laboratory monitoring at initiation of medication therapy: an electronic medical record reminder to the prescribing clinician (EMR), an automated voice message to the patient (AVM), and a pharmacy team outreach (Pharmacy) compared to usual care (UC).
Key facts
- Study ID
- NCT00256386
- Run by
- Kaiser Permanente
- People needed
- 800
- Starts
- 2004-01-01
- Expected to finish
- 2005-03-01
- Last updated by the study team
- 2006-11-30
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Dispensed one of 12 drugs or classes of drugs where baseline safety laboratory monitoring is recommended and labs have not been completed 6 months prior or 5 days after the dispense of the medication.
- 18 years of age or older
- 12-month HMO membership
- drug benefit coverage
- has telephone number
You may not qualify if…
- recommended baseline laboratory monitoring completed
- receives care and/or resides in hospice, nursing home, care outside HMO
- enrolled in other care management program
- nonEnglish speaking needing translation services
Where it is running
- Kaiser Permanente Center for Health Research — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.